482 related articles for article (PubMed ID: 33547771)
1. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.
Cruz C; Gaspar Â; Borrego LM
Acta Med Port; 2021 Mar; 34(3):243. PubMed ID: 33547771
[No Abstract] [Full Text] [Related]
2. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
[No Abstract] [Full Text] [Related]
3. Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
Pitlick MM; Sitek AN; Kinate SA; Joshi AY; Park MA
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):735-738. PubMed ID: 33775902
[No Abstract] [Full Text] [Related]
4. [Allergic reactions to COVID-19 vaccines].
Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccines in Children with Cow's Milk and Food Allergies.
Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Mori F; Paglialunga C; Saretta F; Caffarelli C
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444795
[TBL] [Abstract][Full Text] [Related]
6. Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate.
Hartono SP; Sharma HP; Bundy V; Thompkins JD; Kochis SR; Brooks JP
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2172-2175.e1. PubMed ID: 35842413
[No Abstract] [Full Text] [Related]
7. Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.
Bellanti JA; Settipane RA
Allergy Asthma Proc; 2021 Sep; 42(5):365-367. PubMed ID: 34474705
[No Abstract] [Full Text] [Related]
8. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
9. Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
[TBL] [Abstract][Full Text] [Related]
10. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL
Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440
[TBL] [Abstract][Full Text] [Related]
11. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
Bigini P; Gobbi M; Bonati M; Clavenna A; Zucchetti M; Garattini S; Pasut G
Nat Nanotechnol; 2021 Nov; 16(11):1169-1171. PubMed ID: 34732846
[No Abstract] [Full Text] [Related]
12. COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors.
Razai MS; Oakeshott P; Esmail A; Wiysonge CS; Viswanath K; Mills MC
J R Soc Med; 2021 Jun; 114(6):295-298. PubMed ID: 34077688
[No Abstract] [Full Text] [Related]
13. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
14. COVID-19 Vaccination and the Challenge of Infodemic and Disinformation.
Farooq F; Rathore FA
J Korean Med Sci; 2021 Mar; 36(10):e78. PubMed ID: 33724740
[No Abstract] [Full Text] [Related]
15. Vaccinating against covid-19 in people who report allergies.
Glover RE; Urquhart R; Lukawska J; Blumenthal KG
BMJ; 2021 Jan; 372():n120. PubMed ID: 33461962
[No Abstract] [Full Text] [Related]
16. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
Radice A; Fassio F; Meucci E; Iorno MCL; Macchia D
Eur Ann Allergy Clin Immunol; 2021 Sep; 53(5):240-242. PubMed ID: 33913314
[No Abstract] [Full Text] [Related]
17. Successful COVID-19 Vaccination of a Patient With Hypersensitivity to Polyethylene Glycol and Polysorbate.
Hennighausen I; Pickert J; Mühlenbein S; Möbs C; Pfützner W
J Investig Allergol Clin Immunol; 2022 Jul; 32(4):322-323. PubMed ID: 35234639
[No Abstract] [Full Text] [Related]
18. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
Wolfset N; Pashmineh Azar AR; Phillips CA; Stein M; Rheingold SR; Heimall J; Elgarten CW
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e202-e204. PubMed ID: 38181327
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to SARS CoV-2 Vaccines Containing Polyethylene Glycol in Patients Allergic to Polysorbate 80.
Vidal Oribe I; Venturini Díaz M; Hernández Alfonso P; Del Pozo Gil MD; González Mahave I; Lobera Labairu T
J Investig Allergol Clin Immunol; 2022 Oct; 32(5):403-405. PubMed ID: 34907899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
